Tag Archives: XOMA

Tuesday’s Highlights at Noon: Dynavax (DVAX), Xoma (XOMA), Pan American Silver (PAAS), Tesla (TSLA), Celldex (CLDX)

So far Tuesday, June 30, NASDAQ is up 3.81% and the S&P is up 2.24%. Here are this morning’s most active stocks: Dynavax (DVAX – Research Report), Xoma (XOMA – Research Report), Pan American Silver (PAAS – Research Report), Tesla

Xoma (XOMA) Gets a Buy Rating from Wedbush

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Xoma (XOMA – Research Report), with a price target of $29.00. The company’s shares closed last Tuesday at $23.85. According to TipRanks.com, Moussatos is ranked 0

Analysts Offer Insights on Healthcare Companies: Xoma (NASDAQ: XOMA) and Amgen (NASDAQ: AMGN)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Xoma (XOMA – Research Report) and Amgen (AMGN – Research Report). Xoma (XOMA) In a report released today, Joseph Pantginis from H.C. Wainwright

Monday’s Highlights at Noon: Brainstorm Cell Therapeutics (BCLI), Xoma (XOMA), SunPower (SPWR), Karyopharm Therapeutics (KPTI), Blueprint Medicines (BPMC)

So far Monday, February 17, NASDAQ is down -2.8% and the S&P is up 0.09%. Here are this morning’s most active stocks: Brainstorm Cell Therapeutics (BCLI – Research Report), Xoma (XOMA – Research Report), SunPower (SPWR – Research Report), Karyopharm

Saturday’s Midday Movers: Brainstorm Cell Therapeutics (BCLI), Xoma (XOMA), SunPower (SPWR), Karyopharm Therapeutics (KPTI), Blueprint Medicines (BPMC)

So far Saturday, February 15, NASDAQ is down -2.8% and the S&P is up 0.09%. Here are this morning’s most active stocks: Brainstorm Cell Therapeutics (BCLI – Research Report), Xoma (XOMA – Research Report), SunPower (SPWR – Research Report), Karyopharm

The CEO of Xoma (NASDAQ: XOMA) is Buying Shares

Yesterday, the CEO of Xoma (XOMA – Research Report), James Neal, bought shares of XOMA for $25.96K. Following James Neal’s last XOMA Buy transaction on December 21, 2018, the stock climbed by 12.5%. This recent transaction increases James Neal’s holding